St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of the FlexAbility™ Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.
from Content Keyword RSS http://ift.tt/1zsCbFs
via IFTTT
from Content Keyword RSS http://ift.tt/1zsCbFs
via IFTTT
No comments:
Post a Comment